5031 - 5040 of 8684 Results
Title
Year
-
OPENTitle: GABAA Receptor Benzodiazepine Binding Sites and Motor Impairments in Parkinson’s DiseaseJournal Name: Brain SciencesPublisher: MDPI AGVol: 13Issue #: 12Start Page: 1711End Page: 1711Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci13121711Best OA location URL: https://www.mdpi.com/2076-3425/13/12/1711/pdf?version=1702360159Citation Count: 6
-
RESTRICTEDTitle: The ice test to differentiate essential tremor from Parkinson’s disease tremorJournal Name: Clinical NeurophysiologyPublisher: Elsevier BVVol: 128Issue #: 11Start Page: 2181End Page: 2183Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.clinph.2017.08.015Citation Count: 5
-
OPENTitle: Sex differences in peripheral and central dysregulation of the kynurenine pathway in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-025-00949-6Best OA location URL: https://www.nature.com/articles/s41531-025-00949-6.pdfCitation Count: 3
-
OPENTitle: Alterations of Brain Signal Oscillations in Older Individuals with HIV Infection and Parkinson’s DiseaseJournal Name: Journal of Neuroimmune PharmacologyPublisher: Springer Science and Business Media LLCVol: 16Issue #: 2Start Page: 289End Page: 305Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11481-020-09914-xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7554056Citation Count: 6
-
OPENTitle: In Silico and In Vitro Study towards the Rational Design of 4,4′-Disarylbisthiazoles as a Selective α-Synucleinopathy BiomarkerJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 24Issue #: 22Start Page: 16445End Page: 16445Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms242216445Best OA location URL: https://www.mdpi.com/1422-0067/24/22/16445/pdf?version=1700208971Citation Count: 4
-
RESTRICTEDTitle: Memory impairment in Parkinson’s disease: The retrieval versus associative deficit hypothesis revisited and reconciled.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 33Issue #: 3Start Page: 391End Page: 405Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1037/neu0000503Citation Count: 30
-
OPENTitle: The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorderJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 1Start Page: 88End Page: 98Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27105Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27105Citation Count: 510
- Circulating cell-free mitochondrial DNA levels in Parkinson’s disease are influenced by treatment2020OPENTitle: Circulating cell-free mitochondrial DNA levels in Parkinson’s disease are influenced by treatmentJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s13024-020-00362-yBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-020-00362-yCitation Count: 79
-
OPENTitle: Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in proteinJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00322-xBest OA location URL: https://www.nature.com/articles/s41531-022-00322-x.pdfCitation Count: 9
-
RESTRICTEDTitle: Neuroinflammation and L-dopa-induced abnormal involuntary movements in 6-hydroxydopamine-lesioned rat model of Parkinson's disease are counteracted by combined administration of a 5-HT1A/1B receptor agonist and A2A receptor antagonistJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 196Issue #:Start Page: 108693End Page: 108693Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2021.108693Best OA location URL: https://hdl.handle.net/11584/325357Citation Count: 19